Gerresheimer Publishes Its First Voluntary Sustainability Report Aligned with the CSRD 2025 Results: -31% CO2e, 54% electricity from renewable sources, -63% lost time incident rate Ambitious CO2e reduction target of -52% by 2030 Duesseldorf, July 9, 2026. Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, [ … ]

Gerresheimer Publishes 2025 Annual and Consolidated Financial Statements: Stable Revenue in a Challenging Financial Year   Revenue of EUR 2.3 billion, adjusted EBITDA of EUR 384 million Organic revenue growth of +0.3%, adjusted EBITDA margin at 16.8% Closing of the sale of Centor and comprehensive debt refinancing planned for this year Impleme [ … ]

Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc. Ongoing investigations initiated by the company require more time for the preparation and audit of the annual accounts Sale of US subsidiary Centor to optimize capital and financing structure this year Transformation [ … ]